The expected growth in the next financial year is on the back of
healthy demand from the domestic market given increasing spend on
healthcare along with improving access, Icra said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-industry-likely-to-grow-at-10-13-per-cent-in-fy21-icra/articleshow/73697191.cms
No comments:
Post a Comment